Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1) King, B., Kwon, O., Mesinkovska, N., Ko, J., Dutronc, Y., Wu, W., McCollam, J., Yu, G., Holzwarth, K., DeLozier, A. M., Hordinsky, M. ELSEVIER SCIENCE INC. 2021: B18

View details for Web of Science ID 000689355100080